The weight-loss drug Zepbound was linked to a reduction in obstructive sleep apnea (OSA), according to new research. Pharmaceutical manufacturer Eli Lilly on Wednesday said injections of its obesity ...
GLP-1 medications, such as Ozempic, Zepbound and Wegovy, have emerged as a significant advancement in the treatment of various conditions, including Type 2 diabetes, heart ...
Millions of people in the U.S. have sleep apnea, most of whom aren’t getting treated for it. But a simple daily pill of an ...
Continuous positive airway pressure (CPAP) is the standard treatment for treating obstructive sleep apnea (OSA), but clinicians should remember that weight loss is also an effective approach for ...
The weekly injection is now the first drug treatment option cleared for patients with obesity and moderate-to-severe obstructive sleep apnea, or OSA, which refers to breathing interrupted during sleep ...
SAN DIEGO, Jan. 22, 2026 /PRNewswire/ -- Lofta, a leading provider of direct-to-consumer sleep apnea care, today announced a strategic alliance with Accomplish Health, a leading virtual obesity and ...
With more people taking the weight-loss drugs Wegovy and Zepbound, one question inevitably arises: which one is more ...
If sleep apnea is left untreated, one becomes vulnerable to many lifestyle ailments like diabetes and hypertension.
For decades, cumbersome CPAP machines have been the primary way to help people with sleep apnea. A range of new options has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results